Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 22:41:36 - browse：364

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology

WSS

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

What causes osteoarthritis? Researchers study link to brain protein

TikTok, Instagram influencers need more rules for drug ads

Just how do doctors, lawmakers, and the public define abortion?

The drug industry has found itself all alone in Washington

Just how do doctors, lawmakers, and the public define abortion?

hotspot

Wikipedia

explore

Drug repurposing or repositioning? The language matters

Maisha Meds is a PBM, but don't call it that

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Just how do doctors, lawmakers, and the public define abortion?

In age of alternative facts, a scholarly course on calling out crap

High breast density mammograms need follow

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

First medicine developed to treat MASH expected to be approved soon

Malaria cases in Florida and Texas: Here’s what you need to know

Change Healthcare payments predicted restored March 15

focus

Printout prescription drug information shouldn’t go digital

The inclusion problem at the heart of rehabilitation research

Future doctors need a strong humanities education

Air quality improving but still lags in Black, Hispanic communities

There's an unseen cost to disruptive road

Sen. Paul opposes bill to ban Chinese biotechs

explore

hotspot

knowledge

explore